Similar articles

• Third biannual report of the Cochrane Haematological Malignancies Group.

  Kober T, Skoetz N, Trelle S, Bohlius J, Engert A; Cochrane Haematological Malignancies Group. Kober T, et al. J Natl Cancer Inst. 2005 Aug 17;97(16):E2. doi: 10.1093/jnci/dji258. J Natl Cancer Inst. 2005. PMID: 16106014 Review. No abstract available.
• Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.

  Ke X, Yang Y, Zhao X, Wang L. Ke X, et al. Chin Med J (Engl). 2001 Feb;114(2):196-9. Chin Med J (Engl). 2001. PMID: 11780206
• Acute leukemias.

  Gore JM. Gore JM. JAAPA. 2014 May;27(5):47-8. doi: 10.1097/01.JAA.0000446221.55059.49. JAAPA. 2014. PMID: 24758979 Review. No abstract available.
• Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.

  Westin GF, Dias AL, Go RS. Westin GF, et al. Curr Hematol Malig Rep. 2016 Aug;11(4):271-9. doi: 10.1007/s11899-016-0331-4. Curr Hematol Malig Rep. 2016. PMID: 27177742 Review.
• Hematopoietic stem cell transplantation in hematologic malignancy.

  Archuleta TD, Devetten MP, Armitage JO. Archuleta TD, et al. Panminerva Med. 2004 Mar;46(1):61-74. Panminerva Med. 2004. PMID: 15238882 Review.